James Healy Karuna Therapeutics, Inc. (KRTX) insider trading activity

KRTX Quotes by TradingView

James Healy is of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 18, 2024, when has been sold 33,490 shares (Common Stock) at a price of $330.0 per share, resulting in proceeds of $11,051,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

JAMES HEALY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Sale (or disposition) back to the issuer
$11,051,700 $330.0 p/Share
33,490 Reduced 100.0%
0 Common Stock
Jun 20 2023
BUY
Grant, award, or other acquisition
-
990 Added 2.87%
33,490 Common Stock
Aug 05 2022
BUY
Exercise of conversion of derivative security
$520,000 $16.0 p/Share
32,500 Added 50.0%
32,500 Common Stock

Also insider at

HGEN
HUMANIGEN, INC Healthcare
Director
CHRS
Coherus BioSciences, Inc. Healthcare
Director
BOLT
Bolt Biotherapeutics, Inc. Healthcare
NTRA
Natera, Inc. Healthcare
YMAB
Y-mAbs Therapeutics, Inc. Healthcare
Director
CINC
CinCor Pharma, Inc. Healthcare
Director
AVBP
ArriVent Biopharma, Inc.
Director
RAPP
Rapport Therapeutics, Inc.
Director
BIOA
BioAge Labs, Inc.
JH

James Healy

Menlo Park, CA

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRTX